Central administration of insulin-like growth factor-I decreases depressive-like behavior and brain cytokine expression in mice
2011

Insulin-like Growth Factor-I Reduces Depressive-Like Behavior in Mice

Sample size: 16 publication 10 minutes Evidence: high

Author Information

Author(s): Park Sook-Eun, Dantzer Robert, Kelley Keith W, McCusker Robert H

Primary Institution: University of Illinois at Urbana-Champaign

Hypothesis

Central IGF-I would diminish depressive-like behavior on a background of an inflammatory response by inducing expression of BDNF while decreasing pro-inflammatory cytokine expression.

Conclusion

Central administration of IGF-I significantly reduces depressive-like behavior in mice, even in the presence of inflammation.

Supporting Evidence

  • IGF-I significantly decreased the duration of immobility in the tail suspension test.
  • LPS increased pro-inflammatory cytokine expression, which was decreased by IGF-I.
  • IGF-I increased expression of brain-derived neurotrophic factor (BDNF).
  • Behavioral changes were assessed using established tests for depressive-like behavior.

Takeaway

Giving IGF-I to mice helps them feel less sad, even when they are sick from inflammation.

Methodology

Mice were treated with IGF-I and LPS, and their behavior was assessed using the tail suspension test and mRNA expression of inflammatory markers was analyzed.

Potential Biases

Potential bias due to the use of a single strain of mice and the specific conditions of the experiment.

Limitations

The study was conducted only in male CD-1 mice, which may limit the generalizability of the findings.

Participant Demographics

Male CD-1 mice, 7 to 8 weeks old.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1742-2094-8-12

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication